Voluntary Faculty
Voluntary faculty are typically clinicians or others who are employed outside of the School but make significant contributions to department programs at the medical center or at affiliate institutions.
Voluntary rank detailsSivabalaji Kaliamurthy
Clinical InstructorAbout
Research
Publications
2025
BUPRENORPHINE 2.0
Glaser P, Hinckley J, Kaliamurthy S, Heward B. BUPRENORPHINE 2.0. Journal Of The American Academy Of Child And Adolescent Psychiatry 2025, 64: s427. DOI: 10.1016/j.jaac.2025.07.1025.Peer-Reviewed Original Research72.4 Hallucinogen Use Disorder in Adolescents and Transitional-Age Youth: An Emerging Area of Concern?
Kaliamurthy S. 72.4 Hallucinogen Use Disorder in Adolescents and Transitional-Age Youth: An Emerging Area of Concern? Journal Of The American Academy Of Child And Adolescent Psychiatry 2025, 64: s102-s103. DOI: 10.1016/j.jaac.2025.07.526.Peer-Reviewed Original ResearchCharacterizing cannabis use among adolescents seeking treatment for their substance use
Kumar P, Straton E, Kaliamurthy S. Characterizing cannabis use among adolescents seeking treatment for their substance use. Journal Of Addictive Diseases 2025, ahead-of-print: 1-4. PMID: 40667847, DOI: 10.1080/10550887.2025.2528314.Peer-Reviewed Original ResearchThe Use of Extended-Release Buprenorphine in the Treatment of Adolescent Opioid Use Disorder: A Case Series
Neptune A, Kaliamurthy S. The Use of Extended-Release Buprenorphine in the Treatment of Adolescent Opioid Use Disorder: A Case Series. Journal Of Addiction Medicine 2025, 19: 552-556. PMID: 39898524, DOI: 10.1097/adm.0000000000001447.Peer-Reviewed Original ResearchExtended-release buprenorphineOpioid use disorderCase seriesUse disorderOpioid abstinenceMedical recordsTreatment of opioid use disorderChart review periodNo significant complicationsDuration of treatmentOnset of treatmentMedical records of adolescentsRecords of adolescentsExtended-releaseSublingual buprenorphinePatient ageSignificant complicationsSubcutaneous injectionOpioidBuprenorphinePatientsOutpatient settingTreatment approachesElectronic medical recordsTreatment retention
2024
Brief Report on Outpatient Treatment of Adolescent Opioid Use Disorder
Kaliamurthy S, Straton E, Kumar P, Carleen A. Brief Report on Outpatient Treatment of Adolescent Opioid Use Disorder. Journal Of Addiction Medicine 2024, 19: 230-232. PMID: 39442073, DOI: 10.1097/adm.0000000000001391.Peer-Reviewed Original ResearchOpioid use disorderMonths postintakeAdolescent patientsModerate to severe opioid use disorderMOUD treatmentAddiction clinicsUse disorderPrevalence of opioid use disorderSevere opioid use disorderOutpatient treatmentFentanyl useCharacteristics of adolescentsClinic visitsPatientsAddiction treatmentDemographic dataFentanylIntake appointmentClinicMonthsPostintakeMOUDTreatmentAdolescentsOverdose fatalitiesInitiation of Buprenorphine Treatment of Opioid Use Disorder in Pediatric Emergency Departments.
Kumar P, Kaliamurthy S, Thomas J. Initiation of Buprenorphine Treatment of Opioid Use Disorder in Pediatric Emergency Departments. 2024, 154 PMID: 38966873, DOI: 10.1542/peds.2024-066226.Peer-Reviewed Original ResearchOpioid use disorderTreatment of opioid use disorderPediatric emergency departmentEmergency departmentOpioid withdrawalUse disorderTreatment of opioid withdrawalBuprenorphine treatment of opioid use disorderCases of adolescent patientsED settingPartial opioid agonistSevere opioid use disorderOutpatient addiction clinicInitiation of buprenorphineImprove patient complianceOutpatient follow-upInitiation of medicationFood and DrugOpioid agonistsPediatric patientsCase seriesWithdrawal symptomsAdolescent patientsBuprenorphine initiationPediatric population
2022
Clinical approach to the treatment of e-cigarette use among adolescents
Kaliamurthy S, Camenga DR. Clinical approach to the treatment of e-cigarette use among adolescents. Current Problems In Pediatric And Adolescent Health Care 2022, 52: 101203. PMID: 35534404, DOI: 10.1016/j.cppeds.2022.101203.Peer-Reviewed Educational MaterialsConceptsE-cigarette usePediatric healthcare providersHealthcare providersNicotine replacement therapyOff-label useSerious public health threatYears of ageE-cigarette cessationPublic health threatCessation strategiesReplacement therapyNicotine withdrawalClinical managementPediatric providersClinical approachAmerican AcademyBehavioral treatmentHealth consequencesHealth threatAdolescentsTreatmentProvidersFurther researchTherapySymptomsCommunity based buprenorphine micro-induction in the context of methadone maintenance treatment and fentanyl – Case report
Kaliamurthy S, Jegede O, Hermes G. Community based buprenorphine micro-induction in the context of methadone maintenance treatment and fentanyl – Case report. Journal Of Addictive Diseases 2022, 41: 175-180. PMID: 35377273, DOI: 10.1080/10550887.2022.2051985.Peer-Reviewed Case Reports and Technical NotesConceptsFull opioid agonistsOpioid use disorderFentanyl useOpioid agonistsUse disordersMethadone doseCommunity-based methadone maintenance programIllicit fentanyl useCharacteristics of patientsMethadone maintenance treatmentMethadone maintenance programMaintenance treatmentOutpatient clinicTime of inductionOutpatient settingCommunity clinicsBuprenorphinePatientsMore cliniciansAgonistsDisordersClinicCliniciansDoseWithdrawalGender and Racial Disparity among Addiction Psychiatry Fellows in the United States
Saboor S, Naveed S, Chaudhary A, Ullah I, Safdar B, Kaliamurthy S, Khosa F. Gender and Racial Disparity among Addiction Psychiatry Fellows in the United States. Psychiatric Quarterly 2022, 93: 547-558. PMID: 35083646, DOI: 10.1007/s11126-021-09970-3.Peer-Reviewed Original Research